Cargando…

Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity

The cross-linking of effector cell-bound IgE antibodies by allergens induces the release of inflammatory mediators which are responsible for the symptoms of allergy. We demonstrate that a recombinant hybrid molecule consisting of the major birch (Bet v 1) and grass (Phl p 5) pollen allergen exhibite...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, N., Hofer, G., Gattinger, P., Smiljkovic, D., Blatt, K., Selb, R., Stoecklinger, A., Keller, W., Valent, P., Niederberger, V., Thalhamer, J., Valenta, R., Flicker, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408504/
https://www.ncbi.nlm.nih.gov/pubmed/30850635
http://dx.doi.org/10.1038/s41598-019-39798-8
_version_ 1783401775151185920
author Najafi, N.
Hofer, G.
Gattinger, P.
Smiljkovic, D.
Blatt, K.
Selb, R.
Stoecklinger, A.
Keller, W.
Valent, P.
Niederberger, V.
Thalhamer, J.
Valenta, R.
Flicker, S.
author_facet Najafi, N.
Hofer, G.
Gattinger, P.
Smiljkovic, D.
Blatt, K.
Selb, R.
Stoecklinger, A.
Keller, W.
Valent, P.
Niederberger, V.
Thalhamer, J.
Valenta, R.
Flicker, S.
author_sort Najafi, N.
collection PubMed
description The cross-linking of effector cell-bound IgE antibodies by allergens induces the release of inflammatory mediators which are responsible for the symptoms of allergy. We demonstrate that a recombinant hybrid molecule consisting of the major birch (Bet v 1) and grass (Phl p 5) pollen allergen exhibited reduced allergenic activity as compared to equimolar mixes of the isolated allergens in basophil activation experiments. The reduced allergenic activity of the hybrid was not due to reduced IgE reactivity as demonstrated by IgE binding experiments using sera from allergic patients. Physicochemical characterization of the hybrid by size exclusion chromatography, dynamic light scattering, negative-stain electron microscopy and circular dichroism showed that the hybrid occurred as folded aggregate whereas the isolated allergens were folded monomeric proteins. IgG antibodies raised in rabbits against epitopes of Bet v 1 and Phl p 5 showed reduced reactivity with the hybrid compared to the monomeric allergens. Our results thus demonstrate that aggregation can induce changes in the conformation of allergens and lead to the reduction of allergenic activity. This is a new mechanism for reducing the allergenic activity of allergens which may be important for modifying allergens to exhibit reduced side effects when used for allergen-specific immunotherapy.
format Online
Article
Text
id pubmed-6408504
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64085042019-03-12 Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity Najafi, N. Hofer, G. Gattinger, P. Smiljkovic, D. Blatt, K. Selb, R. Stoecklinger, A. Keller, W. Valent, P. Niederberger, V. Thalhamer, J. Valenta, R. Flicker, S. Sci Rep Article The cross-linking of effector cell-bound IgE antibodies by allergens induces the release of inflammatory mediators which are responsible for the symptoms of allergy. We demonstrate that a recombinant hybrid molecule consisting of the major birch (Bet v 1) and grass (Phl p 5) pollen allergen exhibited reduced allergenic activity as compared to equimolar mixes of the isolated allergens in basophil activation experiments. The reduced allergenic activity of the hybrid was not due to reduced IgE reactivity as demonstrated by IgE binding experiments using sera from allergic patients. Physicochemical characterization of the hybrid by size exclusion chromatography, dynamic light scattering, negative-stain electron microscopy and circular dichroism showed that the hybrid occurred as folded aggregate whereas the isolated allergens were folded monomeric proteins. IgG antibodies raised in rabbits against epitopes of Bet v 1 and Phl p 5 showed reduced reactivity with the hybrid compared to the monomeric allergens. Our results thus demonstrate that aggregation can induce changes in the conformation of allergens and lead to the reduction of allergenic activity. This is a new mechanism for reducing the allergenic activity of allergens which may be important for modifying allergens to exhibit reduced side effects when used for allergen-specific immunotherapy. Nature Publishing Group UK 2019-03-08 /pmc/articles/PMC6408504/ /pubmed/30850635 http://dx.doi.org/10.1038/s41598-019-39798-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Najafi, N.
Hofer, G.
Gattinger, P.
Smiljkovic, D.
Blatt, K.
Selb, R.
Stoecklinger, A.
Keller, W.
Valent, P.
Niederberger, V.
Thalhamer, J.
Valenta, R.
Flicker, S.
Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
title Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
title_full Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
title_fullStr Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
title_full_unstemmed Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
title_short Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
title_sort fusion proteins consisting of bet v 1 and phl p 5 form ige-reactive aggregates with reduced allergenic activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408504/
https://www.ncbi.nlm.nih.gov/pubmed/30850635
http://dx.doi.org/10.1038/s41598-019-39798-8
work_keys_str_mv AT najafin fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT hoferg fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT gattingerp fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT smiljkovicd fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT blattk fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT selbr fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT stoecklingera fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT kellerw fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT valentp fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT niederbergerv fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT thalhamerj fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT valentar fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity
AT flickers fusionproteinsconsistingofbetv1andphlp5formigereactiveaggregateswithreducedallergenicactivity